Canadian Medical and Surgical Knowledge Translation Research Group

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19

Phase 2

Completed

Conditions: COVID-19
Inflammatory Response

Interventions: Drug: Icosapent ethyl

First Posted Date: 2020-06-02

Last Posted Date: 2021-12-22

Lead Sponsor: Canadian Medical and Surgical Knowledge Translation Research Group

Target Recruit Count: 100

Registration Number: NCT04412018

Locations: 🇨🇦
North York Diagnostic and Cardiology Clinic, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy